TLE3 identified as biomarker for taxane use in TN

07rescue

This article has just been released, discussing a newly found biomarker , TLE3, which when present indicates a better response to therapy with a taxane (Taxol, Taxotere) in TN breast cancer.

This discovery still has to be duplicated and validated, but it is nice to know researchers are onto something that will help guide treatment for TNs.

It's in PDF form, so you need to have adobe acrobat to read it.

http://breast-cancer-research.com/content/pdf/bcr2241.pdf